Skip to content
10-K

Annual Report

ACTUATE THERAPEUTICS, INC. ACTU

0001683168-26-002257

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 23.71M sh
Shares Diluted FY 2025 · Dec 31, 2025 21.02M sh
Shares Diluted FY 2025 · Dec 31, 2024 8.37M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$19.21M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$21.84M
Cash And Equivalents FY 2025 · Dec 31, 2025 $13.16M
Stockholders Equity FY 2025 · Dec 31, 2025 $7.92M
Stockholders Equity FY 2025 · Dec 31, 2024 $104.19K
Stockholders Equity FY 2025 · Dec 31, 2023 −$99.63M
Current Liabilities FY 2025 · Dec 31, 2025 $5.71M
Current Liabilities FY 2025 · Dec 31, 2024 $8.8M
Total Liabilities FY 2025 · Dec 31, 2025 $6.11M
Total Liabilities FY 2025 · Dec 31, 2024 $9.21M
Current Assets FY 2025 · Dec 31, 2025 $13.64M
Current Assets FY 2025 · Dec 31, 2024 $9.21M
Total Assets FY 2025 · Dec 31, 2025 $14.04M
Total Assets FY 2025 · Dec 31, 2024 $9.32M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.06
Eps Diluted FY 2025 · Dec 31, 2024 −$3.26
Eps Basic FY 2025 · Dec 31, 2025 −$1.06
Eps Basic FY 2025 · Dec 31, 2024 −$3.26
Sga Expense FY 2025 · Dec 31, 2025 $12.2M
Sga Expense FY 2025 · Dec 31, 2024 $6.48M
Rd Expense FY 2025 · Dec 31, 2025 $10.29M
Rd Expense FY 2025 · Dec 31, 2024 $18.68M
Net Income FY 2025 · Dec 31, 2025 −$22.23M
Net Income FY 2025 · Dec 31, 2024 −$27.29M
Operating Income FY 2025 · Dec 31, 2025 −$22.5M
Operating Income FY 2025 · Dec 31, 2024 −$25.16M